Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia progression among children treated for two years, according to

Marchon Eyewear Australia has appointed Jon Borham to the position of Regional Vice President of Sales.

Astellas will pay 4D Molecular Therapeutics (4DMT) US$20 million upfront to use its viral vector for a rare monogenic eye disease in a deal

The work of proud Warnman woman and Martumili artist, Helen Dale Samson, is featured on a range of limited-edition frames produced by Specsavers in